Latest Capital Funding News

Theta Gold Mines Limited has released an optimised feasibility study for its TGME Gold Mine Project, revealing a substantial increase in project value with a 14.5-year life of mine and US$1.2 billion in free cash flow.

Australian Vanadium Limited has locked in a US$10 million secured loan from major shareholder RCF to advance its flagship vanadium project and prepare for a significant government battery storage tender.

ENRG Elements Ltd has announced a renounceable entitlement offer to raise up to $1.6 million, priced at a 50% discount, to fund gold-focused business development and exploration in Central Asia.

KGL Resources updates on its Jervois Copper Project optimisations and financing progress, welcoming Resource Capital Fund as a new significant shareholder. The company is capitalising on higher metal prices and exploring critical mineral opportunities.

Tasmea Limited has completed a fully underwritten A$43 million institutional placement, aiming to accelerate acquisitions, reduce debt, and enhance its chances of joining the ASX 300 Index.

Core Lithium has launched a $10 million Share Purchase Plan offering eligible shareholders the chance to buy new shares at the same price as a recent institutional placement, aiming to bolster working capital and support key project developments.

Sayona Mining has completed its merger with Piedmont Lithium, creating a new lithium entity with equal ownership and a refreshed board. The combined company, soon to be renamed Elevra Lithium, aims to strengthen its position in the global energy transition.

Apiam Animal Health has entered a Process Deed granting Adamantem exclusivity to pursue a $0.88 per share acquisition proposal. The Independent Board Committee signals intent to recommend the deal, pending due diligence and shareholder approval.

Sayona Mining has secured shareholder approval for its merger with Piedmont Lithium, with completion slated for August 30, 2025. The deal promises to reshape the lithium supply landscape and unlock significant growth potential.

Rhythm Biosciences has announced a $3.75 million placement to accelerate the commercial launch of its ColoSTAT® cancer detection test and expand its geneType™ product suite into key markets. The capital raise includes director participation and attaching options, pending shareholder approval.

Microequities Asset Management Group reported a robust FY25 with significant profit growth and a new private credit product launch, signaling a strategic diversification and positive outlook for FY26.

Magnetite Mines Limited has announced a pro rata renounceable rights issue to raise up to $2.65 million, aiming to advance its flagship Razorback iron ore project in South Australia. The offer includes free attaching options and is partially underwritten, reflecting the company’s strategic push towards securing funding and completing key project milestones.